Linda O’Connor

713 total citations
7 papers, 174 citations indexed

About

Linda O’Connor is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Linda O’Connor has authored 7 papers receiving a total of 174 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Immunology and 3 papers in Molecular Biology. Recurrent topics in Linda O’Connor's work include CAR-T cell therapy research (3 papers), Immunotherapy and Immune Responses (3 papers) and vaccines and immunoinformatics approaches (2 papers). Linda O’Connor is often cited by papers focused on CAR-T cell therapy research (3 papers), Immunotherapy and Immune Responses (3 papers) and vaccines and immunoinformatics approaches (2 papers). Linda O’Connor collaborates with scholars based in Australia and Russia. Linda O’Connor's co-authors include Christopher Schmidt, J. Alejandro López, Michael G. E. OʼRourke, Catherine Lanagan, K.A.O. Ellem, Gulietta M. Pupo, Cathy Lanagan, Mitchell Stark, Alberto Pinzón‐Charry and Colin Furnival and has published in prestigious journals such as PLoS ONE, Molecular Cancer Therapeutics and Neoplasia.

In The Last Decade

Linda O’Connor

7 papers receiving 173 citations

Peers

Countries citing papers authored by Linda O’Connor

Since Specialization

Citations

This map shows the geographic impact of Linda O’Connor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linda O’Connor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linda O’Connor more than expected).

Fields of papers citing papers by Linda O’Connor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linda O’Connor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linda O’Connor. The network helps show where Linda O’Connor may publish in the future.

Co-authorship network of co-authors of Linda O’Connor

This figure shows the co-authorship network connecting the top 25 collaborators of Linda O’Connor. A scholar is included among the top collaborators of Linda O’Connor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linda O’Connor. Linda O’Connor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

#	Work	Indexed citations
1	High Efficiency Ex Vivo Cloning of Antigen-Specific Human Effector T Cells 2014 ·PLoS ONE ·Michelle A. Neller, (unknown), Catherine Lanagan, Linda O’Connor, Antonia L. Pritchard, (unknown), Christopher Schmidt	3
2	Melanomas of unknown primary have a mutation profile consistent with cutaneous sun‐exposed melanoma 2013 ·Pigment Cell & Melanoma Research ·Ken Dutton‐Regester, Hojabr Kakavand, Lauren G. Aoude, Mitchell Stark, Michael G. Gartside, Peter A. Johansson, Linda O’Connor, Cathy Lanagan, Varsha Tembe, Gulietta M. Pupo, Lauren E. Haydu, Christopher Schmidt, Graham J. Mann, John F. Thompson, Richard A. Scolyer, Nicholas K. Hayward	41
3	A High-Throughput Panel for Identifying Clinically Relevant Mutation Profiles in Melanoma 2012 ·Molecular Cancer Therapeutics ·Ken Dutton‐Regester, Darryl Irwin, (unknown), Lauren G. Aoude, Varsha Tembe, Gulietta M. Pupo, Cathy Lanagan, (unknown), Linda O’Connor, Michael G. E. OʼRourke, Richard A. Scolyer, Graham J. Mann, Christopher Schmidt, Adrian C. Herington, Nicholas K. Hayward	1
4	Identification of TFG (TRK‐fused gene) as a putative metastatic melanoma tumor suppressor gene 2012 ·Genes Chromosomes and Cancer ·Ken Dutton‐Regester, Lauren G. Aoude, Derek J. Nancarrow, Mitchell Stark, Linda O’Connor, Cathy Lanagan, Gulietta M. Pupo, Varsha Tembe, (unknown), Michael G. E. OʼRourke, Richard A. Scolyer, Graham J. Mann, Christopher Schmidt, Adrian C. Herington, Nicholas K. Hayward	24
5	Dendritic cell immunotherapy for stage IV melanoma 2007 ·Melanoma Research ·Michael G. E. OʼRourke, (unknown), Catherine Lanagan, (unknown), Linda O’Connor, Gregory J. Slater, David M. Thomas, J. Alejandro López, (unknown), K.A.O. Ellem, Christopher Schmidt	42
6	Immunological characteristics correlating with clinical response to immunotherapy in patients with advanced metastatic melanoma 2006 ·Immunology and Cell Biology ·(unknown), (unknown), David M. Purdie, Catherine Lanagan, Linda O’Connor, Michael G. E. OʼRourke, (unknown), (unknown), K.A.O. Ellem, (unknown), J. Alejandro López, Christopher Schmidt	18
7	A Population of HLA-DR+ Immature Cells Accumulates in the Blood Dendritic Cell Compartment of Patients with Different Types of Cancer 2005 ·Neoplasia ·Alberto Pinzón‐Charry, (unknown), R. Laherty, Tammy Maxwell, David Walker, Robert A. Gardiner, Linda O’Connor, Christopher Pyke, Christopher Schmidt, Colin Furnival, J. Alejandro López	45

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact